Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2002
11/06/2002EP1254659A1 Stable emulsion compositions
11/06/2002EP1254658A1 Remedies
11/06/2002EP1254268A1 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides
11/06/2002EP1254266A1 Methods and materials relating to alpha-2-macroglobulin-like polypeptides and polynucleotides
11/06/2002EP1254260A1 Methods for diagnosing and treating heart disease
11/06/2002EP1254251A2 Neurosteroids as markers for alzheimer's disease
11/06/2002EP1254246A1 Methods and materials relating to transforming growth factor alpha-like polypeptides and polynucleotides
11/06/2002EP1254242A1 17 human secreted proteins
11/06/2002EP1254238A2 Novel elongase gene and method for producing multiple-unsaturated fatty acids
11/06/2002EP1254235A2 Drug metabolizing enzymes
11/06/2002EP1254234A1 Haemophilus influenza outer membrane protein and use thereof in vaccination
11/06/2002EP1254222A1 Human gaba receptor proteins and polynucleotides encoding the same
11/06/2002EP1254214A2 Human protein kinases and protein kinase-like enzymes
11/06/2002EP1254212A2 Methods of preparing and using a viral vector library
11/06/2002EP1254176A2 Trade molecules and uses related thereto
11/06/2002EP1254174A2 Human cyr61
11/06/2002EP1254138A1 Pyridine derivatives inhibiting angiogenesis and/or vegf receptor tyrosine kinase
11/06/2002EP1254137A1 PYRIDO 2,3-d]PYRIMIDINE-2,7-DIAMINE KINASE INHIBITORS
11/06/2002EP1254136A1 FACTOR Xa INHIBITORS WITH ARYL-AMIDINES AND DERIVATIVES, AND PRODRUGS THEREOF
11/06/2002EP1254134A2 1,3-dihydro-2h-indol-2-one derivatives,and their use as ligands for v1b or v1b and v1a arginine-vasopressin-receptors
11/06/2002EP1254133A2 Indol-3-yl derivatives
11/06/2002EP1254132A1 Food product and process
11/06/2002EP1254131A1 Extraction of flavonoids
11/06/2002EP1254124A1 Dipeptide nitrile cathpsin k inhibitors
11/06/2002EP1254123A1 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors
11/06/2002EP1254121A1 Preparation of sulfonamides
11/06/2002EP1254120A1 Use of pyrimidine endothelin antagonists in companion animals
11/06/2002EP1254118A2 Substituted 1,2,3,4- tetrahydroquinoline-2-carboxylic acid derivatives
11/06/2002EP1254116A1 Alpha v integrin receptor antagonists
11/06/2002EP1254114A2 Melanocortin receptor agonists and antagonists
11/06/2002EP1254111A1 Novel vitamin d analogues
11/06/2002EP1253966A2 Substances and agents for positively influencing collagen
11/06/2002EP1253945A2 Ace inhibitor-vasopressin antagonist combinations
11/06/2002EP1253937A2 Methods of therapy with thrombin derived peptides
11/06/2002EP1253935A2 Use of vascular endothelial growth factor, placenta growth factor or both for preventing or treating ischemic diseases or stroke
11/06/2002EP1253931A2 Utilization of protein kinase inhibitor alpha
11/06/2002EP1253928A2 Novel haptotactic peptides
11/06/2002EP1253926A1 Compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor
11/06/2002EP1253925A1 Tetrahydropyrimidone inhibitors of fatty acid binding protein and method
11/06/2002EP1253917A2 Use of substituted 4-amino-1-phenylbutan-2-ol compounds as medicaments
11/06/2002EP1097159B1 Phosphinous and phosphonic acid derivatives used as medicaments
11/06/2002EP0910355B1 Traitement and prevention of adverse effects of reactive oxygen species
11/06/2002EP0901373B1 Alpha v Beta 3 ANTAGONISTS
11/06/2002EP0781280B1 Derivatives of benzopyran and of benzothiopyran, their preparation and their use as agonists of dopaminergic receptors
11/06/2002EP0773959B1 Adrenergic receptor
11/06/2002CN1378551A 嘌呤衍生物 Purine derivatives
11/06/2002CN1378550A Partial or full A1 agonists-N6 heterocyclic 5' thio substituted adenosine devivatives
11/06/2002CN1378543A Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activity
11/06/2002CN1378541A Inhibitors of c-JUN N-terminal kinase (JNK) and other protein kinases
11/06/2002CN1378537A 嘧啶衍生物 Pyrimidine derivatives
11/06/2002CN1378534A Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of coagulation cascade
11/06/2002CN1378533A Phenoxypropylamine compounds
11/06/2002CN1378532A Substituted 1,5-dihydropyrrol-2-on derivatives as NMDA receptor antagonists for treatment of pain
11/06/2002CN1378531A Substituted pyrolidine-2,3,4-trion-3-oxime derivatives useful as NMDA receptor antagonists
11/06/2002CN1378528A Use of carbonylamino derivatives against CNS disorders
11/06/2002CN1378527A Biaryl ether derivatives useful as monoamine reuptake inhibitors
11/06/2002CN1378472A Synergy between low molecular weight heparin and platelet aggregation inhibitor, providing combination therapy for prevention and treatment of various thromboembolic disorders
11/06/2002CN1378459A Treatment of auto immune diseases with antagonists which bind to B cell surface markers
11/06/2002CN1378457A Methods and compositions useful for modulation of angiogenesis using protein kinase Raf and Ras
11/06/2002CN1378455A Use of diterpenoid triepoxides as anti-proliferative agent
11/06/2002CN1378443A Cationic liposome delivery of taxanes to angiogenic blood vessels
11/06/2002CN1377969A Prourokinase variant capable of being activated by urokinase or itself and its coding gene, preparing method and use
11/06/2002CN1377896A Seaweed polyose product and its preparing method and use
11/06/2002CN1377887A Polypeptide for inhibiting growth and migration of blood vessel endothelial cell and endothelial stem cell and its preparing method and use
11/06/2002CN1377880A Compound for curing vascular complication, its preparing method and treating use
11/06/2002CN1377689A Traditional Chinese medicine injection for curing cardiovascular and cerebrovascular diseases and fundus disease and its preparing method
11/06/2002CN1377688A Extracting process for decoction of poria, Bighead Atractylodes, cinnamom and Lirorice and its medicinal use
11/06/2002CN1377679A Traditional Chinese medicine particulate preparation for curing cardiovascular and cerebrovascular diseases and its preparing method
11/06/2002CN1377678A Traditional Chinese medicine particulate preparation for curing cardiovascular and cerebrovascular diseases and its preparing method
11/06/2002CN1377677A Chinese patented medicine for curing cardio-vascular and cerebrovascular diseases and its preparing method
11/06/2002CN1377675A Pepper-pueraria root compound Chinese medicine preparation and its preparing process
11/06/2002CN1377670A Long life tea for curing various diseases
11/06/2002CN1377658A Liquid for eliminating phlegm and clearing away heat in pericardium
11/06/2002CN1093856C Substituted sulfonic acid N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclamide compounds
11/06/2002CN1093852C 维生素ｄ酰胺衍生物 Amide derivatives of vitamin d
11/06/2002CN1093767C Protein kinase C inhibitors
11/06/2002CN1093760C Use of carbazole compounds for treating congenstive heart failure medicine
11/06/2002CA2408401A1 Compositions containing folic acid and reduced folate
11/05/2002US6476264 N-(4-carbamimidoyl-phenyl)-glycine derivatives
11/05/2002US6476209 Polynucleotides, materials incorporating them, and methods for using them
11/05/2002US6476195 Secreted protein HNFGF20
11/05/2002US6476193 NLK1 protein and NLK1 protein complexes
11/05/2002US6476077 N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists
11/05/2002US6476060 4,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activity
11/05/2002US6476049 1-formyl-n-(2-(4-(5h-dibenzo(a,d)cyclohepten-5-ylidene)-1 -piperidinyl)) ethyl isonipecotic acid amide or analogs thereof
11/05/2002US6476044 Use of morphine derivatives as medicaments for the treatment of neuropathic problems
11/05/2002US6476041 1,4 substituted piperidinyl NMDA/NR2B antagonists
11/05/2002US6476038 Amino substituted pyrazolo[1,5,-a]-1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazines
11/05/2002US6476037 L-arginine and phosphodiesterase (PDE) inhibitor synergism
11/05/2002US6476033 Medicaments containing doxazosin mesylate of crystalline modification D
11/05/2002US6476031 Quinazoline derivatives as medicaments
11/05/2002US6476029 7-alkyl- and cycloalkyl-substituted imidazotriazinones
11/05/2002US6476028 Compounds and methods
11/05/2002US6476026 Compounds and compositions as protease inhibitors
11/05/2002US6476025 Phenylphennanthridines with PDE-IV inhibiting activity
11/05/2002US6476023 Aromatic heterocyclic compounds as anti-inflammatory agents
11/05/2002US6476022 Oxathiepino[6,5-b]dihydropyridines, and related compositions and methods
11/05/2002US6476020 Imidazo-benzazepine compounds, their compositions and uses
11/05/2002US6476010 Orally administering to a post-menopausal woman a fat soluble vitamin and a fat soluble vitamin absorption increasing effective amount of l-carnitine or salts
11/05/2002US6475986 Uses of THANK, a TNF homologue that activates apoptosis
1 ... 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 ... 1595